Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Breast cancer following ovarian cancer in BRCA mutation carriers.

JAMA surgery - 1 Dec 2014

Gangi Alexandra, Cass Ilana, Paik Daniel, Barmparas Galinos, Karlan Beth, Dang Catherine, Li Andrew, Walsh Christine, Rimel Bobbie J, Amersi Farin F

Abstract excerpt

IMPORTANCE: BRCA mutation carriers are at increased risk of developing breast cancer. However, the incidence of breast cancer after a diagnosis of epithelial ovarian cancer (EOC), one of the tubal/peritoneal cancers collectively referred to as pelvic serous carcinomas, is not well known. Optimal breast cancer surveillance and detection for these patients have also not been well characterized. OBJECTIVES: To...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to BRCA1 Protein
Share to Diagnosis, Differential

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to DNA, Neoplasm

Share to Incidence

Share to Neoplasms, Multiple Primary

Share to Ovarian Neoplasms

Share to Survival Rate

Share to United States

Source

Identifiers

PMID: 25372568
DOI: 10.1001/jamasurg.2014.1081

Genes

BRCA1
BRCA2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Breast cancer following ovarian cancer in BRCA mutation carriers.PMID 25372568Read ↗

Breast cancer surveillance following ovarian cancer in BRCA mutation carriers.Semantic proximity Read ↗

Breast Cancer Surveillance Following Ovarian Cancer in BRCA Mutation Carriers.Semantic proximity Read ↗

Occult and subsequent cancer incidence following risk-reducing surgery in BRCA mutation carriers.Semantic proximity Read ↗

Breast cancer incidence in BRCA mutation carriers with ovarian cancer: A longitudal observational study.Semantic proximity Read ↗

Managing hereditary breast cancer risk in women with and without ovarian cancer.Semantic proximity Read ↗

Risk of Breast Cancer After Ovarian Cancer in Women With a Pathogenic/Likely Pathogenic Variant in BRCA1 or BRCA2.Semantic proximity Read ↗

Risk of metachronous breast cancer after BRCA mutation-associated ovarian cancer.Semantic proximity Read ↗

Risk-reducing salpingo-oophorectomy (RRSO) in BRCA mutation carriers: experience with a consecutive series of 111 patients using a standardized surgical-pathological protocol.Semantic proximity Read ↗

Breast cancer prevention in patients with gBRCA-mutated ovarian cancer.Semantic proximity Read ↗

The challenging screen detection of ovarian cancer in BRCA mutation carriers adhering to a 6-month follow-up program: results from a 6-years surveillance.Semantic proximity Read ↗

Breast cancer detection among Irish BRCA1 & BRCA2 mutation carriers: a population-based study.Semantic proximity Read ↗

Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.